IL6 and Alzheimer disease: Diverse studies highlight elevated proinflammatory cytokines, chemokines, acute phase reactants, and other inflammatory molecules in the circulation of AD patients, with some of these cytokines as interleukin-6 (IL-6), positively associated with cognitive decline and AD progression (92).